Simulations Plus, Inc. (NASDAQ:SLP) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07Submission of Matters to a Vote of Security Holders:
On February 23, 2017, Simulations Plus, Inc., a California
corporation (the Company), held its annual meeting of
shareholders (the Annual Meeting). The following proposals were
submitted to a vote of security holders at the meeting.
1. Proposal No. 1: To elect to the Board of
Directors four (4) directors, to serve until the next Annual
Meeting of Shareholders of the Company or until their successors
are elected and qualified, subject to prior death, resignation or
removal.
2. Proposal No. 2: To ratify the appointment of
Rose, Snyder and Jacobs as our independent registered public
accounting firm for the Company for the fiscal year ending August
31, 2017.
3. Proposal No. 3: Approval of Adoption of the
Companys 2017 Equity Incentive Plan
4. Proposal No. 4: Advisory Vote to Approve
Named Executive Officer Compensation
The above proposals were approved and the results of the
balloting at the meeting are summarized in the following tables.
|
Proposal |
Votes For |
Votes Against | Votes Abstaining |
Votes Withheld |
Broker- Non votes |
Total (a) |
|
| (1) | Walter Woltosz | 10,176,439 | 1,491,646 | 4,237,165 | 15,905,250 | ||
| (1) | Dr. Thaddeus H. Grasela | 10,146,013 | 1,522,072 | 4,237,165 | 15,905,250 | ||
| (1) | Dr. John K. Paglia | 11,614,244 | 53,841 | 4,237,165 | 15,905,250 | ||
| (1) | Dr. David Ralph | 11,549,458 | 118,627 | 4,237,165 | 15,905,250 | ||
| (2) | Appointment of Rose, Snyder and Jacobs | 15,732,687 | 49,518 | 123,045 | 15,905,250 | ||
| (3) | Adoption of the Companys 2017 Equity Incentive Plan | 9,450,304 | 2,162,094 | 55,687 | 4,237,165 | 15,905,250 | |
| (4) | Approval of Named Executive Officer Compensation | 11,501,341 | 110,931 | 55,813 | 4,237,165 | 15,905,250 |
(a) Total Proxy Shares on record date on December 29, 2016
17,230,478 out of which 15,905,250 shares were reported.
Item 8.01Other Events
On February 23, 2017, the Company held its annual meeting of
shareholders. A copy of PowerPoint presentation for the meeting
are attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
This report on Form 8-K (the Report), including the disclosures
set forth herein, contains certain forward-looking statements
that involve substantial risks and uncertainties. When used
herein, the terms anticipates, expects, estimates, believes and
similar expressions, as they relate to us or our management, are
intended to identify such forward-looking statements.
Forward-looking statements in this Report or hereafter, including
in other publicly available documents filed with the Securities
and Exchange Commission (the Commission), reports to the
stockholders of Simulations Plus, Inc., a California corporation
(the Company or us, our or we) and other publicly available
statements issued or released by us involve known and unknown
risks, uncertainties and other factors which could cause our
actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. Such future results are based
upon management’s best estimates based upon current conditions
and the most recent results of operations. These risks include,
but are not limited to, the risks set forth herein and in such
other documents filed with the Commission, each of which could
adversely affect our business and the accuracy of the
forward-looking statements contained herein. Our actual results,
performance or achievements may differ materially from those
expressed or implied by such forward-looking statements.
Item 9.01Financial Statements and Exhibits
(d)Exhibits
99.1Power Point Presentation on February 23, 2017.
About Simulations Plus, Inc. (NASDAQ:SLP)
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs. Simulations Plus, Inc. (NASDAQ:SLP) Recent Trading Information
Simulations Plus, Inc. (NASDAQ:SLP) closed its last trading session up +0.05 at 10.05 with 27,776 shares trading hands.